DEEPIKA PAKIANATHAN
CIK 1270734 · last filed 2026-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.33M
Companies
7
Total Filings
67
Lifetime Open-Market Net
$5.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TBPH | Director | 64,074 | $16.89 | $1.08M | $0 | 7 | 2026-06-16 |
| KPTI | Director | 30,795 | $7.09 | $218.3K | $1.40M | 19 | 2026-05-26 |
| MREO | Director | 105,244 | $0.31 | $32.6K | -$466.2K | 4 | 2026-02-27 |
| Calithera Biosciences, Inc. (CALA) Delisted | Director | 0 | $0.00 | $0 | $4.95M | 10 | 2023-01-31 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | 30,000 | $2.16 | $64.8K | $0 | 2 | 2021-12-30 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Director | — | — | — | $0 | 4 | 2018-05-25 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 99,627 | — | — | $0 | 12 | 2015-06-25 |
Recent Filings · Page 4 of 7
67 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-04-23 | — | U | −2,010,542 | $0 | |
| 2018-06-25 | — | Grant (A) | — | $0 | |
| 2018-06-20 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2018-06-04 | Calithera Biosciences, Inc. (CALA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-25 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-16 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2017-06-13 | Calithera Biosciences, Inc. (CALA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-02 | — | Grant (A) | — | $0 | |
| 2017-05-26 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-24 | — | Grant (A) | — | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.